ORI-113

N/A

Report date: 2023/07/28 17:06:21
NME

Base Information

Drug NameORI-113
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionHuntingtin degradersProteolysis
TargetsHuntingtin
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrigami Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrigami Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A